Adamantyl analogs of 2'-(3-dimethylaminopropylthio)cinnamanilide.
D000813:Anilides / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001952:Bridged-Ring Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D002934:Cinnamates / Q000138:chemical synthesis* / Q000494:pharmacology; D003516:Cycloparaffins / Q000138:chemical synthesis* / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D007106:Immune Sera; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000138:chemical synthesis / Q000494:pharmacology; D051379:Mice; D012756:Sheep / Q000276:immunology; D013045:Species Specificity
D000813:Anilides; D001952:Bridged-Ring Compounds; D002934:Cinnamates; D003516:Cycloparaffins; D007106:Immune Sera; D007166:Immunosuppressive Agents